Cargando…
LCAT protects against Lipoprotein‐X formation in a murine model of drug‐induced intrahepatic cholestasis
Familial lecithin:cholesterol acyltransferase (LCAT) deficiency (FLD) is a rare genetic disease characterized by low HDL‐C levels, low plasma cholesterol esterification, and the formation of Lipoprotein‐X (Lp‐X), an abnormal cholesterol‐rich lipoprotein particle. LCAT deficiency causes corneal opaci...
Autores principales: | Amar, Marcelo J. A., Freeman, Lita A., Nishida, Takafumi, Sampson, Maureen L., Pryor, Milton, Vaisman, Boris L., Neufeld, Edward B., Karathanasis, Sotirios K., Remaley, Alan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935572/ https://www.ncbi.nlm.nih.gov/pubmed/31893124 http://dx.doi.org/10.1002/prp2.554 |
Ejemplares similares
-
Lipoprotein X Causes Renal Disease in LCAT Deficiency
por: Ossoli, Alice, et al.
Publicado: (2016) -
A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X
por: Neufeld, Edward B., et al.
Publicado: (2022) -
Endothelial Expression of Scavenger Receptor Class B, Type I Protects against Development of Atherosclerosis in Mice
por: Vaisman, Boris L., et al.
Publicado: (2015) -
ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid
por: Neufeld, Edward B., et al.
Publicado: (2019) -
Cholestasis in Benign Recurrent Intrahepatic Cholestasis 2
por: Arthur Lorio, Eric, et al.
Publicado: (2020)